- Email: [email protected]
CARDIOVASCULAR CLINICS: DIAGNOSTIC METHODS IN CARDIOLOGY (vol 6, No. 3)
THE BOOKSHELF CARDIOVASCULAR CLINICS: DIAGNOSTIC METHODS IN CARDIOLOGY (vol 6, No.3). "¥.mteo. by NOBLE O. FOWLER. Philadelphia, F. A. Davis Co., 1975,468 pp, 338 illus, $32.00. This book is a compendium of chapters submitted
by a diverse group of authors. The theme of the book has been followed well, with very few exceptions. One can question the appropriateness of an extensive chapter on gallop rhythm in a "methods" book; yet the subsequent sections on auscultation, phonocardiography, and pulse recordings are excellent. The later chapter on apexcardiography is smewhat redundant but is well written 'unto itself. The entire burgeoning area of "noninvasive" graphics is extensively covered, with particular !trength in echocardiography and phonocardiography. The chapters on exercise electrocardiography, ambulatory monitoring of arrhythmias, and His bundle electrocardiography are particularly thorough. Thisbook continues to place a major emphasis on systolic time intervals, an emphasis which may not bewarranted in studies of individual patients as distinct from studies of groups of patients. The value of the chapter on computer analysis of the electrocardiogram is limited; the chapter on vectorcardiography is basically similar to the book by the same author. Similarly, the chapters on pulse blood How and on Doppler-assisted study of arterial and venous ~ow are of limited value. In general, the book is well printed, the illustrations are clear and appropriate, and the references Me a reasonable balance between the critical and fue desirable. On the whole, the book is faithful to i~ title theme; most chapters also stand alone as educationally valuable reviews of the chapter topic. Ihis book is likely to be of value to the generalist, as lVell as to those physicians whose professional activines emphasize the chest.
Richard A. Carleton, M.D., F.C.C.P. Hanover,NH tARDIOLOGY SPECIALTY BOARD REVIEW. By JAMES W. HOLSINGER, JR., and VINCENT F. MrscIA. Flushing, NY, Medical Examination Publishing Co., Inc., 1975, 188 pp, $12.00. The ominous specter of an impending specialty ~ard examination stimulates the insecurities in the ]ost stalwart of us. Does this explain the profusion ~d presumed popularity of relatively low-priced ~perbacks such as this one, consisting solely of
After the "2-Step" Test, the Third Step in Angina* Therapy Is ...
NITRO-BID®6.5
(nitroglycerin 6.5 mg) Plateau CAPS®
Comparing electrocardiographic responses to standard exercise following placebo or sustainedrelease nitroglycerin (NITRO-BID® [nitroglycerin] capsules), " ...6.5 mg doses produced a favorable response .Such findings indicate that large doses of nitrate escape degradation in the liver." 1 In another study ," .. .over a 4-hour per iod the average work -induced ischem ic area increased after placebo by 25 per cent , whereas ove r the same period the average work- induced ischemic area decreased after peroral nitroglycerin (NITROBI D®[nitroglycerin] capsules) by 41 per cent." 2
Also available when titration is important
NITRO-BID®2.5
(nitroglycerin 2.5 mg) Plateau CAPS® --------, *r:--:-:--:-Ind ications Based on a review o f this d ru g by the Nation al Acade my of Scie nc es - Nation al Researc h Cou nc il and/o r o the r info r ma tio n, FDA has c lass ified the ind ication s as follow s: Possibly effec tive: For the m anag ement, pro phy laxis or treat ment o f angi na l attac ks . Final c lassi fication of the lesstha n-effective indic atio ns req uires furt her investigatio n. Contraindications: Recent m yoc ard ial infa rc tion , severe
References: 1 Ru ssek H I: W hat cons titutes adequate medical therapy for the pat ient wit h angina pec to ris? Geriatrics 29 : 109 -118 . 1974. 2 . Wendkos MH . Mes hu lam N: Comparative effects of placebo and sus tai ned- release nitrog lyce ri n in ang inal subjects. J Ctir: Pharmacal 13 : 160 - 166 . 19 7 3 Ano ther patient benefit produc t from
IIVIIMAUFnON __
19
anemia . glaucoma. incr eased intracr anial pressure. idiosyncrasy. hypote nsion . Precautions: For O RA L, not su blingual. use . If blurring of vision or dryness of mo uth occurs , discontinue d r ug . Tolerance may develop on long-term usage . Adverse Reactions: Occasional transient hea daches. Ove rdose may cause flushi ng , headac hes, tac hycardia . dizziness. Dosage: O ne ca psu le two o r th ree tim es da ily at 8 to 12-ho ur inter vals .
LABORATOR IES . INC .
KA NSAS CITY , M ISSOURI 64137
by a diverse group of authors. The theme of the book has been followed well, with very few exceptions. One can question the appropriateness of an extensive chapter on gallop rhythm in a "methods" book; yet the subsequent sections on auscultation, phonocardiography, and pulse recordings are excellent. The later chapter on apexcardiography is smewhat redundant but is well written 'unto itself. The entire burgeoning area of "noninvasive" graphics is extensively covered, with particular !trength in echocardiography and phonocardiography. The chapters on exercise electrocardiography, ambulatory monitoring of arrhythmias, and His bundle electrocardiography are particularly thorough. Thisbook continues to place a major emphasis on systolic time intervals, an emphasis which may not bewarranted in studies of individual patients as distinct from studies of groups of patients. The value of the chapter on computer analysis of the electrocardiogram is limited; the chapter on vectorcardiography is basically similar to the book by the same author. Similarly, the chapters on pulse blood How and on Doppler-assisted study of arterial and venous ~ow are of limited value. In general, the book is well printed, the illustrations are clear and appropriate, and the references Me a reasonable balance between the critical and fue desirable. On the whole, the book is faithful to i~ title theme; most chapters also stand alone as educationally valuable reviews of the chapter topic. Ihis book is likely to be of value to the generalist, as lVell as to those physicians whose professional activines emphasize the chest.
Richard A. Carleton, M.D., F.C.C.P. Hanover,NH tARDIOLOGY SPECIALTY BOARD REVIEW. By JAMES W. HOLSINGER, JR., and VINCENT F. MrscIA. Flushing, NY, Medical Examination Publishing Co., Inc., 1975, 188 pp, $12.00. The ominous specter of an impending specialty ~ard examination stimulates the insecurities in the ]ost stalwart of us. Does this explain the profusion ~d presumed popularity of relatively low-priced ~perbacks such as this one, consisting solely of
After the "2-Step" Test, the Third Step in Angina* Therapy Is ...
NITRO-BID®6.5
(nitroglycerin 6.5 mg) Plateau CAPS®
Comparing electrocardiographic responses to standard exercise following placebo or sustainedrelease nitroglycerin (NITRO-BID® [nitroglycerin] capsules), " ...6.5 mg doses produced a favorable response .Such findings indicate that large doses of nitrate escape degradation in the liver." 1 In another study ," .. .over a 4-hour per iod the average work -induced ischem ic area increased after placebo by 25 per cent , whereas ove r the same period the average work- induced ischemic area decreased after peroral nitroglycerin (NITROBI D®[nitroglycerin] capsules) by 41 per cent." 2
Also available when titration is important
NITRO-BID®2.5
(nitroglycerin 2.5 mg) Plateau CAPS® --------, *r:--:-:--:-Ind ications Based on a review o f this d ru g by the Nation al Acade my of Scie nc es - Nation al Researc h Cou nc il and/o r o the r info r ma tio n, FDA has c lass ified the ind ication s as follow s: Possibly effec tive: For the m anag ement, pro phy laxis or treat ment o f angi na l attac ks . Final c lassi fication of the lesstha n-effective indic atio ns req uires furt her investigatio n. Contraindications: Recent m yoc ard ial infa rc tion , severe
References: 1 Ru ssek H I: W hat cons titutes adequate medical therapy for the pat ient wit h angina pec to ris? Geriatrics 29 : 109 -118 . 1974. 2 . Wendkos MH . Mes hu lam N: Comparative effects of placebo and sus tai ned- release nitrog lyce ri n in ang inal subjects. J Ctir: Pharmacal 13 : 160 - 166 . 19 7 3 Ano ther patient benefit produc t from
IIVIIMAUFnON __
19
anemia . glaucoma. incr eased intracr anial pressure. idiosyncrasy. hypote nsion . Precautions: For O RA L, not su blingual. use . If blurring of vision or dryness of mo uth occurs , discontinue d r ug . Tolerance may develop on long-term usage . Adverse Reactions: Occasional transient hea daches. Ove rdose may cause flushi ng , headac hes, tac hycardia . dizziness. Dosage: O ne ca psu le two o r th ree tim es da ily at 8 to 12-ho ur inter vals .
LABORATOR IES . INC .
KA NSAS CITY , M ISSOURI 64137